Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Affamed, Astellas, Astrazeneca, Celltrion, Certa, Incannex, Iovance, Jacobio, Mabwell, Otsuka, Sanofi.